Issue Date: June 5, 2017
Cambrex expands its Swedish plant
Cambrex is expanding its large-scale active pharmaceutical ingredient operation in Karlskoga, Sweden, introducing continuous-flow production of high-purity drug intermediates. The expansion will also add multipurpose batch reactors ranging from 4 to 12 m3, a 9-m3 hydrogenation reactor, and an upgraded control room. Work on the project is set to be completed later this year.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society